Latest Headlines

Antipsychotics Safe for Pregnant Women
Antipsychotics Safe for Pregnant Women
The results of the largest study of its kind to date indicate that new antipsychotic medications—including quetiapine, olanzapine, and risperidone—do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.
The Parable of the Salt and the Evolving Medical Consensus
Changes in the way we think about sodium intake and cardiovascular risk, calcium supplementation, and other topics should remind us all of the advice we heard on the first day of medical school: 50% of what you learn here is wrong or going to disappear over your career; we just don’t know which 50%.
ACC 2015
More than 13,000 physicians and cardiovascular team members attended the ACC 2015 meeting in San Diego on March 14-16, 2015. In this issue of Cardiology Review, we focus on 6 important studies presented at ACC 2015: LEGACY, OSLER, PEGASUS, EMBRACE-STEMI, MATRIX, and CoreValve.
LDL: How Low Should We Go?
In this segment of the Peer Exchange, the panelists discuss clinical factors that should be taken into consideration when placing a patient on statin therapy to lower their LDL levels. They also talk about the strengths and weaknesses of the clinical data being used to inform treatment decisions.
Strong Evidence on the Positive Health Effects of Yogurt
Studies show that nutrient-dense yogurt may benefit individuals with lactose intolerance, constipation and diarrheal diseases, hypertension, cardiovascular diseases, diabetes, and certain types of cancer.
Can Ezetimibe Improve Statin Outcomes?
The panelists discuss clinical outcomes in patients with acute coronary syndrome treated with statins and other medications and review the implications of the results from the IMPROVE-IT trial.

Most Popular

$vacMongoViewPlus$ $vAR$